Skip to main content
Premium Trial:

Request an Annual Quote

Molecular Devices, Cytena Partner on Launch of Single-Cell Printer System

NEW YORK (GenomeWeb) – Molecular Devices announced today that it has signed an agreement to help launch Cytena's CloneSelect single-cell printer in North America.

The printer uses microfluidics and real-time image analysis to isolate single cells and provide visual documentation of monoclonality for use in cell line development. It has particular use in antibody discovery, enabling the automated isolation of single cells into standard 96- and 384-well plates for a wide range of cell types, according to Molecular Devices.

Specific terms of the partnership were not disclosed.

"Our customers have been seeking ways to bring biologics and biosimilars to market more quickly," Molecular Devices President Greg Milosevich said in a statement. "We are very excited about this product and how it allows us to expand our toolset in the fast-growing biotherapeutics market."